Erika Ferguson

Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran 2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus

Bruce D. Roth, C. John Blankley, Alexander Chucholowski et al. · Journal of Medicinal Chemistry · 1991 · 183 citations · Full text

Rna Expression in the Early Characterization of Hepatotoxicants in Wistar Rats by High–Density Dna Microarrays

Steven J. Bulera, Susan Eddy, Erika Ferguson et al. · Hepatology · 2001 · 183 citations · Full text

Pathology, High–density Dna Microarrays, Gene Expression-profiling Technology +20

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

Thomas Bocan, Erika Ferguson, W. McNally et al. · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1992 · 86 citations

Nonhepatic Sterol Synthesis, Hmg-coa Reductase Inhibitors, Hepatology +11

Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix

Uday Saxena, Erika Ferguson, C L Bisgaier · Journal of Biological Chemistry · 1993 · 84 citations · Full text

Lipoprotein Lipase, Low Density Lipoprotein, Apolipoprotein E +15

Selective Inhibition of Tumor Necrosis Factor–Induced Vascular Cell Adhesion Molecule-1 Gene Expression by a Novel Flavonoid

Joachim Wölle, Russell R. Hill, Erika Ferguson et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1996 · 61 citations